KRAS and colorectal cancer: In one study, cell lines were generated from a patient with concurrent BRAFV600E-mutant melanoma and KRAS-mutant colorectal cancer, with paradox breakers inhibiting the BRAFV600E-mutant cells without paradoxically enhancing the growth of the KRAS-mutant cells [105].